v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Series Seed convertible preferred stock
Series A convertible preferred stock
Series B convertible preferred stock
Series C convertible preferred stock
Temporary equity, beginning balance (in shares) at Dec. 31, 2024           3,963,963 5,704,161 11,370,621 18,628,970
Temporary equity, beginning balance at Dec. 31, 2024           $ 13,014 $ 25,235 $ 110,791 $ 181,328
Convertible Preferred Stock                  
Conversion of convertible preferred stock to common stock upon closing of initial public offering (in shares)           (3,963,963) (5,704,161) (11,370,621) (18,628,970)
Conversion of convertible preferred stock to common stock upon closing of initial public offering           $ (13,014) $ (25,235) $ (110,791) $ (181,328)
Temporary equity, ending balance (in shares) at Mar. 31, 2025           0 0 0 0
Temporary equity, ending balance at Mar. 31, 2025           $ 0 $ 0 $ 0 $ 0
Beginning balance (in shares) at Dec. 31, 2024   4,722,763              
Beginning balance at Dec. 31, 2024 $ (163,713) $ 5 $ 17,000 $ 368 $ (181,086)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Conversion of convertible preferred stock to common stock upon closing of initial public offering (in shares)   27,149,206              
Conversion of convertible preferred stock to common stock upon closing of initial public offering 330,367 $ 27 330,340            
Issuance of common stock from initial public offering, net of issuance costs (in shares)   12,176,467              
Issuance of common stock from initial public offering, net of issuance costs 199,570 $ 12 199,558            
Vesting of restricted common stock awards (in shares)   43,681              
Vesting of restricted common stock awards 0                
Stock-based compensation expense 2,094   2,094            
Unrealized loss on marketable securities (67)     (67)          
Net loss (16,482)       (16,482)        
Ending balance (in shares) at Mar. 31, 2025   44,092,117              
Ending balance at Mar. 31, 2025 $ 351,769 $ 44 548,992 301 (197,568)        
Temporary equity, beginning balance (in shares) at Dec. 31, 2025           0 0 0 0
Temporary equity, beginning balance at Dec. 31, 2025           $ 0 $ 0 $ 0 $ 0
Temporary equity, ending balance (in shares) at Mar. 31, 2026           0 0 0 0
Temporary equity, ending balance at Mar. 31, 2026           $ 0 $ 0 $ 0 $ 0
Beginning balance (in shares) at Dec. 31, 2025 44,723,585 44,723,585              
Beginning balance at Dec. 31, 2025 $ 306,833 $ 45 562,602 540 (256,354)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Exercise of common stock options (in shares) 352,066 352,066              
Exercise of common stock options $ 2,225   2,225            
Stock-based compensation expense 6,553   6,553            
Unrealized loss on marketable securities (624)     (624)          
Net loss $ (26,779)       (26,779)        
Ending balance (in shares) at Mar. 31, 2026 45,075,651 45,075,651              
Ending balance at Mar. 31, 2026 $ 288,208 $ 45 $ 571,380 $ (84) $ (283,133)